IMVT (Immunovant Inc) Sof foyda

IMVT (Immunovant) - kompaniyaning tovar belgisi

Immunovant, Inc. (IMVT) immunologik rivojlanishi YaIM va mavsumiylikdan mustaqil bo'lib, yuqori makro-barqarorlikka ega. GURU.Markets platformasida kompaniyaning hisobotdagi sof foyda grafigi joriy daromad tebranishlarini vizuallashtiradi, bunda -0.53 qiymati ushbu holatni aks ettiradi. Barqaror moliyaviy holati monoklonal antitelalar tadqiqotlarining dinamikasi bilan qo'llab-quvvatlanmoqda, strategik ittifoqlar esa tibbiyot markazlari bilan hamkorlikda noyob patologiyalar uchun innovatsion terapiyalarni yaratishga yordam bermoqda.

IMVT (Immunovant, Inc.) Sof foyda tarixi 04.07.2022dan 31.10.2026gacha

Immunovant (IMVT) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Immunovant Therapeutics|IMVT - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi Immunovant Therapeutics|IMVT - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati Immunovant|IMVT - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi immunovant.com|IMVT - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Immunovant, Inc.|IMVT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Immunovant Inc|IMVT - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Immunovant Therapeutics|IMVT - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Immunovant|Shoshilinch likvidlik immunovant.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
IMVT - Sof foyda
Kompaniyaning jamlanma tahlili:Immunovant, Inc.
Immunovant Corp asosiy tovari

Klinik sinovlar natijalari va dori vositalarining tartibga soluvchi organlar tomonidan tasdiqlanishiga muvaffaqiyati bog'liq bo'lgan Immunovant, Inc. (IMVT) uchun haqiqiy pul oqimi generatsiyasini kuzatish juda muhimdir. Kompaniyaning moliyaviy va biznes operatsiyalari natijasi bo'lgan ushbu ko'rsatkich daromadlarning kunlik kapital qiymatini aks ettiradi, bu esa investorlarga aktiv qiymatini ob'ektiv baholash hamda yuqori tebranishlar davrida yoki bemorlarda nojo'ya ta'sirlar yuzaga kelganida spekulyativ kutishlar uchun ortiqcha to'lov qilishdan qochish imkonini beradi.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda KNSA (Kiniksa Pharmaceuticals Ltd)|Sof moliyaviy natija Grifols Biemat (GRFS)|ADPT - Kompaniyaning sof foydasi|celldex.com (CLDX) - Sof daromad|Aurinia Pharmaceuticals Inc. (AUPH) - Kompaniyaning sof foydasi|Sof daromad BioCryst Pharmaceuticals, Inc.|Sof daromad VERA|Sof foyda Dianthus Corp|Kompaniyaning sof foydasi Pharvaris N.V. (PHVS)|AbCellera Biologics Inc. - Kompaniya foydasi|Sof foyda TRML (Tourmaline Bio)|Precigen Inc (PGEN) - Kompaniyaning sof daromadi|Pharming - Sof foyda|Sof moliyaviy natija Nektar Corp NKTR|Upstream Bio Inc (UPB) - Kompaniyaning sof foydasi|Sof daromad zenasbio.com|Kompaniyaning sof foydasi Immunome|Sof daromad Gossamer Bio Inc (GOSS)|Sof daromad KALV (KalVista Pharmaceuticals Inc)|Sof foyda Septerna Pharma (SEPN)|Kompaniyaning sof foydasi Pieris Pharmaceuticals PVLA|SVRA: Kompaniya foydasi|RIGL - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi AnaptysBio Inc|ATXS (Astria Pharma) - Sof daromad|ENGN (enGene Corp) - Kompaniyaning sof foydasi|RAPT (RAPT Therapeutics, Inc.) - Sof foyda|Sof foyda Aerovate|Kompaniyaning sof foydasi Aclaris Therapeutics, Inc. (ACRS)|Kyverna Therapeutics Inc. - Kompaniya foydasi|Tiziana Life Sciences PLC - Sof daromad|Soliqlar to‘langandan keyingi foyda CABA (Cabaletta Bio Inc)|VTYX: Sof daromad|Yakuniy foyda THTX (theratech.com)|AVTX: Sof foyda|ELDN - Sof moliyaviy natija|Kompaniyaning sof foydasi Agenus Inc|Kompaniya foydasi CLYM (Climb Bio, Inc)|Sof foyda ZURA|Sof daromad atyrpharma.com ATYR|Adagene Inc. - Sof daromad|Sof moliyaviy natija ImageneBio (IMA)|Shattuck Therapeutics - Sof foyda|Sof moliyaviy natija Equillium, Inc. EQ|connectbiopharm.com (CNTB) - Kompaniyaning sof foydasi|Sof daromad Immunic|Sof daromad ATRA|Kompaniyaning sof foydasi IFRX|Sof daromad XFOR (X4 Pharma)|Soliqlar to‘langandan keyingi foyda ACET|Kompaniyaning sof foydasi Celularity CELU|INMB (inmunebio.com) - Soliqdan keyingi foyda|Barinthus Biotherapeutics plc - Sof foyda|Yakuniy foyda KZR (Kezar Life Sciences Inc.)|SABS: Sof foyda|Akari Therapeutics, Plc (AKTX) - Sof foyda|Kompaniyaning sof foydasi Enlivex Therapeutics Ltd|QTTB: Yakuniy foyda|Kompaniyaning sof foydasi GeoVax (GOVX)|Sof daromad Edesa Biotech Inc EDSA|Sof foyda IBIO (iBio Corp)|Sof foyda Carisma Therapeutics Inc CARM|XTLB: Sof daromad|Yakuniy foyda BOLT (Bolt Biotherapeutics)|HCWB: Sof foyda|APVO - Sof moliyaviy natija|Kompaniyaning sof foydasi AIM ImmunoTech|Sof daromad Aditxt Corp (ADTX)|Kompaniyaning sof foydasi GRI Bio, Inc. (GRI)|Sof daromad xortx.com XRTX|Vyome Holdings - Sof daromad|Sof foyda Revelation Biosciences Inc REVB|INDP - Kompaniyaning sof foydasi|SCNI (BiondVax Pharmaceuticals) - Kompaniya foydasi|CALI: Sof foyda|Kompaniyaning sof daromadi Affimed N.V. (AFMD)|ALLK (Allakos Inc) - Sof foyda|HOOKIPA (HOOK) - Sof moliyaviy natija|Kompaniyaning sof foydasi IGM Biosciences, Inc. (IGMS)|Sof daromad iTeos Pharma ITOS|Kompaniyaning sof foydasi Ocean Biomedical, Inc. OCEA|TCBP - Sof daromad|THRD: Sof daromad